Voyager Therapeutics (VYGR) reported new data from its two preclinical programs targeting tau for the treatment of Alzheimer’s disease. Data on ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad ...

Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average rating of “Buy” by the nine analysts that are covering the company, Marketbeat.com reports. Eight ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical muri ...

Bank of New York Mellon Corp lessened its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The firm ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At close: March 28 at 4:00:01 PM EDT ...

The decision comes as the Voyager spacecraft face diminishing power supplies due to the gradual decay of their radioactive ...

The future of the North Powers Boulevard extension to Interstate 25 has reached another important step with the full ...

Voyager episodes hint at the amazing and much stronger character Kes could've been if Jennifer Lien hadn't left in season 4.